NCT03636620View on ClinicalTrials.gov

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

Transcatheter arterial chemoembolization

Transcatheter arterial chemoembolization

DEVICE

radiofrequency ablation/microwave ablation

radiofrequency ablation/microwave ablation

Trial Locations (1)

200032

liver cancer institute ,Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03636620 - TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial | Biotech Hunter | Biotech Hunter